Clinical Trials in San Francisco

Showing 3361-3380 of 6,211 trials

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

NCT03120936

The Stay Study is a multi-site, open-label HIV pre-exposure prophylaxis (PrEP) demonstration project for advancing PrEP delivery in the San Francisco Bay Area Transgender Community. Approximately 188 HIV-uninfected participants will be enrolled at 4 sites in San Francisco and Fremont and will be provided Truvada to take orally once daily as PrEP.

Transgender PersonsPre-Exposure Prophylaxis

Public Health Foundation Enterprises, Inc.158 participantsStarted Aug 2017

Fremont, California, United States • San Francisco, California, United States • San Francisco, California, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

NCT01201356

The purpose of this study was to collect long-term safety and tolerability, long-term efficacy, and health outcome data in all patients currently ongoing in the fingolimod multiple sclerosis clinical development program. This study combined all currently ongoing Phase II and III fingolimod extension studies as well as ongoing and newly planned studies into one single long-term extension protocol that provided patients with continuous treatment until fingolimod was registered, commercially available, and reimbursed in the respective countries.

Relapsing Forms of Multiple Sclerosis

Novartis Pharmaceuticals4,125 participantsStarted Sep 2010

Cullman, Alabama, United States • Oceanside, California, United States • Sacramento, California, United States +455 more locations

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Find Trials by Condition in San Francisco

Complex Ventral Hernia Repair Using Biologic or Synthetic Mesh

Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease

A Phase II Study of M2951 in SLE

Empower Korean Families to End Tobacco Use & Smoking Exposure

A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI

Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer

Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome

A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Anti-VEGF vs. Prompt Vitrectomy for VH From PDR

Gene Expression That Predicts Radiation Exposure in Humans

Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt

A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor

Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) Incompetence

Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence

Wide Frequency Band Test of Hearing in Veterans